Overview
Friederike Graf-Schmidt practices in Munich, Germany. Graf-Schmidt is rated as an Advanced expert by MediFind in the treatment of Oligodendroglioma. Their top areas of expertise are Astrocytoma, Glioblastoma, Glioma, and Gliomatosis Cerebri.
Their clinical research consists of co-authoring 66 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 3 articles in the study of Oligodendroglioma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- AstrocytomaGraf-Schmidt isDistinguished. Learn about Astrocytoma.
- GlioblastomaGraf-Schmidt isDistinguished. Learn about Glioblastoma.
- GliomaGraf-Schmidt isDistinguished. Learn about Glioma.
- Gliomatosis CerebriGraf-Schmidt isDistinguished. Learn about Gliomatosis Cerebri.
- Advanced
- Brain TumorGraf-Schmidt isAdvanced. Learn about Brain Tumor.
- OligodendrogliomaGraf-Schmidt isAdvanced. Learn about Oligodendroglioma.
- Experienced
- HypopituitarismGraf-Schmidt isExperienced. Learn about Hypopituitarism.
- NecrosisGraf-Schmidt isExperienced. Learn about Necrosis.